Sequence based engineering and optimization of single chain antibodies

Details for Australian Patent Application No. 2008267733 (hide)

Owner ESBATech, an Alcon Biomedical Research Unit LLC

Inventors Borras, Leonardo; Urech, David

Agent Davies Collison Cave

Pub. Number AU-A-2008267733

PCT Pub. Number WO2009/000098

Priority 60/937,112 25.06.07 US; 61/069,057 12.03.08 US

Filing date 25 June 2008

Wipo publication date 31 December 2008

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

24 December 2009 PCT application entered the National Phase

  PCT publication WO2009/000098 Priority application(s): WO2009/000098

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008267734-Methods of modifying antibodies, and modified antibodies with improved functional properties

2008267724-Substituted fused pyrimidines as antagonists of GPR105 activity